Randomized Phase II Trial of Individualized Adaptive Radiotherapy Using During-Treatment FDG-PET/CT and Modern Technology in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Additional Information on ACRIN.org: Displayed below is an interactive view of the study record as it appears on acrin.org.